株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

膀胱癌:世界の治験動向

Bladder Cancer Global Clinical Trials Review, H2, 2015

発行 GlobalData 商品コード 212840
出版日 ページ情報 英文 105 Pages
即納可能
価格
本日の銀行送金レート: 1USD=114.81円で換算しております。
Back to Top
膀胱癌:世界の治験動向 Bladder Cancer Global Clinical Trials Review, H2, 2015
出版日: 2015年08月19日 ページ情報: 英文 105 Pages
概要

当レポートでは、世界における膀胱癌治療薬の臨床試験のデータを提供し、国別の動向、臨床試験数、有望な治療薬、および主な企業や研究機関別の臨床試験の状況をまとめています。

目次

イントロダクション

  • 膀胱癌
  • レポートガイダンス

臨床試験 地域別

  • 臨床試験 国別
    • 臨床試験に寄与している上位5ヵ国 - アジア太平洋地域
    • 臨床試験に寄与している上位5ヵ国 - 欧州
    • 臨床試験に寄与している上位国 - 北米
    • 臨床試験に寄与している上位国 - 中東およびアフリカ
    • 臨床試験に寄与している上位国 - 中南米

臨床試験:G7 諸国

臨床試験:G7 諸国 治験ステータス別

臨床試験:E7 諸国

臨床試験:E7 諸国 治験ステータス別

臨床試験 相別

  • 進行中の治験 相別

臨床試験 治験ステータス別

未完了の治験

期間ごとの被験者数

有力なスポンサー

主な治験参加企業

有望な治療薬

臨床試験 プロファイル

  • 臨床試験概要: 上位企業
    • GlaxoSmithKline plc
    • Eli Lilly and Company
    • Pfizer Inc.
    • Spectrum Pharmaceuticals, Inc.
    • Sanofi
    • Merck & Co., Inc.
    • Bayer AG
    • F. Hoffmann-La Roche Ltd.
    • Endo Health Solutions Inc.
    • Bristol-Myers Squibb Company
  • 臨床試験概要: トップレベルの大学 / 研究機関 / 病院
    • National Cancer Institute
    • Memorial Sloan Kettering Cancer Center
    • European Organization for Research and Treatment of Cancer
    • The University of Texas M. D. Anderson Cancer Center
    • National Bladder Cancer Collaborative Group
    • Southwest Oncology Group
    • Medical Research Council Clinical Trials Unit
    • University of Michigan
    • Eastern Cooperative Oncology Group
    • Medical Research Council

5つの主要な臨床試験プロファイル

付録

図表一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDHC2823CTIDB

GlobalData's clinical trial report, "Bladder Cancer Global Clinical Trials Review, H2, 2015" provides an overview of Bladder Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Bladder Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Bladder Cancer
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Bladder Cancer to Oncology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Bladder Cancer to Oncology Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Bladder Cancer
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Bladder Cancer Therapeutics Clinical Trials
  • Prominent Drugs
    • Latest Clinical Trials News on Bladder Cancer
      • Aug 10, 2015: BioClin Therapeutics Initiates Phase 2 Clinical Trial Evaluating B-701 for Treatment of Urothelial Cell Carcinoma
      • Jul 13, 2015: In a pivotal study, Roche's investigational immunotherapy atezolizumab shrank tumours in people with a specific type of bladder cancer
      • Jun 01, 2015: Roche presents encouraging update on metastatic bladder cancer data for atezolizumab (MPDL3280A, anti-PDL1)
      • Jun 01, 2015: OncoGenex Announces Data from Borealis-1 Trial Showing Clinical Benefit with Apatorsen in Metastatic Bladder Cancer
      • May 20, 2015: OncoGenex To Present Phase II Study Data On Apatorsen At ASCO 2015 Annual Meeting
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • GlaxoSmithKline Plc
      • Clinical Trial Overview of GlaxoSmithKline Plc
      • Eli Lilly and Company
      • Clinical Trial Overview of Eli Lilly and Company
      • F. Hoffmann-La Roche Ltd.
      • Clinical Trial Overview of F. Hoffmann-La Roche Ltd.
      • Merck & Co., Inc.
      • Clinical Trial Overview of Merck & Co., Inc.
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • Novartis AG
      • Clinical Trial Overview of Novartis AG
      • Celgene Corporation
      • Clinical Trial Overview of Celgene Corporation
      • Oncogenex Pharmaceuticals, Inc.
      • Clinical Trial Overview of Oncogenex Pharmaceuticals, Inc.
      • Bayer AG
      • Clinical Trial Overview of Bayer AG
      • AstraZeneca Plc
      • Clinical Trial Overview of AstraZeneca Plc
    • Clinical Trial Overview of Top Institutes / Government
      • National Cancer Institute
      • Clinical Trial Overview of National Cancer Institute
      • Memorial Sloan Kettering Cancer Center
      • Clinical Trial Overview of Memorial Sloan Kettering Cancer Center
      • European Organization for Research and Treatment of Cancer
      • Clinical Trial Overview of European Organization for Research and Treatment of Cancer
      • SWOG
      • Clinical Trial Overview of SWOG
      • The University of Texas M. D. Anderson Cancer Center
      • Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center
      • Eastern Cooperative Oncology Group
      • Clinical Trial Overview of Eastern Cooperative Oncology Group
      • Medical Research Council
      • Clinical Trial Overview of Medical Research Council
      • University Hospitals Birmingham NHS Foundation Trust
      • Clinical Trial Overview of University Hospitals Birmingham NHS Foundation Trust
      • University of Chicago
      • Clinical Trial Overview of University of Chicago
      • Aarhus University
      • Clinical Trial Overview of Aarhus University
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Bladder Cancer Therapeutics, Global, Clinical Trials by Region, 2015*
  • Bladder Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Bladder Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Bladder Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015*
  • Bladder Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2015*
  • Bladder Cancer Therapeutics Clinical Trials, North America, Top Countries, 2015*
  • Bladder Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015*
  • Bladder Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2015*
  • Proportion of Bladder Cancer to Oncology Clinical Trials, G7 Countries (%), 2015*
  • Bladder Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Bladder Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Bladder Cancer to Oncology Clinical Trials, E7 Countries (%), 2015*
  • Bladder Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Bladder Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Bladder Cancer Therapeutics, Global, Clinical Trials by Phase, 2015*
  • Bladder Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2015*
  • Bladder Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Bladder Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Bladder Cancer Therapeutics, Global, Suspended Clinical Trials, 2015*
  • Bladder Cancer Therapeutics, Global, Withdrawn Clinical Trials, 2015*
  • Bladder Cancer Therapeutics, Global, Terminated Clinical Trials, 2015*
  • Bladder Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Bladder Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015*
  • Bladder Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Bladder Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Bladder Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline Plc, 2015*
  • Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2015*
  • Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015*
  • Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2015*
  • Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015*
  • Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015*
  • Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Celgene Corporation, 2015*
  • Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Oncogenex Pharmaceuticals, Inc., 2015*
  • Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2015*
  • Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca Plc, 2015*
  • Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2015*
  • Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2015*
  • Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by European Organization for Research and Treatment of Cancer, 2015*
  • Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by SWOG, 2015*
  • Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2015*
  • Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eastern Cooperative Oncology Group, 2015*
  • Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical Research Council, 2015*
  • Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospitals Birmingham NHS Foundation Trust, 2015*
  • Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Chicago, 2015*
  • Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Aarhus University, 2015*

List of Figures

  • Bladder Cancer Therapeutics, Global, Clinical Trials by Region (%), 2015*
  • Bladder Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Bladder Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Bladder Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015*
  • Bladder Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015*
  • Bladder Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2015*
  • Bladder Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015*
  • Bladder Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2015*
  • Proportion of Bladder Cancer to Oncology Clinical Trials, G7 Countries (%), 2015*
  • Bladder Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Bladder Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Bladder Cancer to Oncology Clinical Trials, E7 Countries (%), 2015*
  • Bladder Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Bladder Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Bladder Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2015*
  • Bladder Cancer Therapeutics, Global, Clinical Trials In Progress by Phase, 2015*
  • Bladder Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Bladder Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Bladder Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Bladder Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015*
  • Bladder Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Bladder Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Bladder Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • GlobalData Methodology
Back to Top